Toxicodendron dermatitis: Poison ivy, oak, and sumac

Wilderness and Environmental Medicine

Volumn 17, Issue 2, 2006, Pages 120-128

  Gladman, Aaron C ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Poison ivy; Poison oak; Poison sumac; Rhus dermatitis; Toxicodendron dermatitis; Urushiol

Indexed keywords

BENTONITE; BETAMETHASONE; CORTICOSTEROID; DERMOFILM; FATTY ACID; HOLLISTER MOISTURE BARRIER; HYDROCORTISONE; HYDROPEL; IVY BLOCK; IVY SHIELD; LAUROYL SARCOSINATE; ORGANIC SOLVENT; PIMECROLIMUS; PROTECTIVE AGENT; SHIELD SKIN; STOKOGARD; SURFACTANT; TACROLIMUS; TECNU; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; UNIDERM; URUSHIOL; ZANFEL;

AGRICULTURE; ANACARDIACEAE; CASHEW NUT; CLINICAL FEATURE; CONTACT DERMATITIS; DERMATITIS; FORESTRY; GINKGO BILOBA; HUMAN; MANGO; MEDLINE; PATHOPHYSIOLOGY; POISON IVY; REVIEW; SCHINUS TEREBINTHIFOLIUS; SEMECARPUS; TOXICODENDRON DIVERSILOBUM; TOXICODENDRON PUBESCENS; TOXICODENDRON RYDBERGII; TOXICODENDRON VERNICIFLUA; TOXICODENDRON VERNIX;

EID: 33745127731     PISSN: 10806032     EISSN: None     Source Type: Journal    
DOI: 10.1580/PR31-05.1     Document Type: Review

References (54)

1. Pariser DM, Ceilley RI, Lefkovits AM, Katz BE, Paller AS. Poison ivy, oak and sumac. Derm. Insights. 2003;4(1):26-28.
2. Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1996. National Center for Health Statistics. Vital Health Stat. 1998;13(134):26.
3. Oltman J, Hensler R. Poison oak/ivy and forestry workers. Clin Dermatol. 1986;4(2):213-216.
4. Epstein WL. Occupational poison ivy and oak dermatitis. Dermatol Clin. 1994;12:511-516.
5. Fisher AA. Poison ivy/oak/sumac. Part II: specific features. Cutis. 1996;58:22-24.
6. Fisher AA, Mitchell JC. Toxicodendron plants and spices. In: Rietschel RL, ed. Fisher's Contact Dermatitis. 4th ed. Baltimore, MD: Williams & Wilkins; 1995:461-523.
7. Epstein WL. The poison ivy picker of Pennypack Park: the continuing saga of poison ivy. J Invest Dermatol. 1987;88(suppl 3):7-11.
8. Marks JG. Poison ivy and poison oak allergic contact dermatitis. J Allergy Clin Immunol. 1989;9:497-506.
9. Baer RL. Poison ivy dermatitis. Cutis. 1990;46:34-36.
10. Epstein WL, Epstein JH. Plant-induced dermatitis. In: Auerbach PS, ed. Wilderness Medicine. 3rd ed. St. Louis, MO: Mosby-Year Book; 1995:843-861.
11. Natural Resources Conservation Service, United States Department of Agriculture. PLANTS Database. Available at: http://plants.usda.gov/index.html. Accessed on 11/15/05; search term: Toxicodendron.
12. Gartner BL, Wasser C, Rodriguez E, Epstein WL. Seasonal variation of urushiol content in poison oak. Am J Contact Dermatitis. 1993;4:33-36.
13. Symes WF, Dawson CR. Poison ivy urushiol. J Am Chem Soc. 1954;76:2959-2963.
14. Baer H. Chemistry and immunochemistry of poisonous Anacardiaceae. Clin Dermatol. 1986;4:152-159.
15. Guin JD, Beaman JH. Toxicodendrons of the United States. Clin Dermatol. 1986;4:137-148.
16. Dawson CR. The chemistry of poison ivy. Trans N Y Acad Sci. 1956;18:427-443.
17. Symes WF, Dawson CR. Separation and structural determination of the olefinic components of poison ivy urushiol, cardonal and cardol. Nature. 1953;171:841-842.
18. Du Y, Oshima R, Kumanotai J. Reversed-phase liquid Chromatographie separation and identification of constituents of urushiol in the sap of the lac tree. J Chromatogr. 1985;A284:463-473.
19. Oka K, Fumio S, Tadashi Y, Akiko S. A study of cross-reactions between mango contact allergens and urushiol. Contact Dermatitis. 2004;51:292-296.
20. Knight TE, Boll P, Epstein WL, Prasad AK. Resorcinols and catechols. A clinical study of cross-reactivity. Am J Contact Dermatol. 1996;7:138-145.
21. Klilah H, Ido W, Arieh I. Exploring the mango-poison ivy connection: the riddle of discriminative plant dermatitis Contact Dermatitis. 2005;52:3-5.
22. Kalish RS. Recent developments in the pathogenesis of allergic contact dermatitis. Arch Dermatol. 1991;127:1558-1563.
23. Barker JN. Role of epidermal keratinocytes in allergic contact dermatitis. Contact Dermatitis. 1992;26(3):145-148.
24. Kupper TS. Production of cytokines by epithelial tissues A new model for cutaneous inflammation. Am J Dermatopathol. 1989;11(1):69-73.
25. Mydlarski PR, Katz AM, Mamelak, AJ, Sauder DN. Contact dermatitis. In: Adkinson NF, ed. Middleton's Allergy: Principles and Practice. 6th ed. St. Louis, MO: Mosby; 2003:1581-1593.
26. Wakabayashi T, Hu DL, Tagawa YI, et al. IFNγ and TNF are involved in urushiol-induced contact hypersensitivity in mice. Immunology Cell Bio. 2005;83:18-24.
27. Williams JV, Light J, Marks JG. Individual variations in allergic contact dermatitis from urushiol. Arch Dermatol. 1999;135:1002-1003.
28. Guin JD. Reaction time in experimental poison ivy dermatitis. Contact Dermatitis. 1980;6:289.
29. Lejman E, Stoudemayer T, Grove G, Kligman AM. Age differences in poison ivy dermatitis. Contact Dermatitis. 1984;11:163-167.
30. Kurlan JG, Lucky AW. Black spot poison ivy: a report of 5 cases and a review of the literature. J Am Acad Dermatol. 2001;45:246-249.
31. Werchniak AE, Schwarzenberger K. Poison ivy: an underreported cause of erythema multiforme. J Am Acad Dermatol. 2004;51:159-160.
32. Tanner TL. Rhus (Toxicodendron) dermatitis. Primary Care. 2000;27(2):493-502.
33. Juckett G. Plant dermatitis-possible culprits go far beyond poison ivy. Postgrad Med. 1996;100(3):159-163.
34. Brook I, Frazier EH, Yeager JK. Microbiology of infected poison ivy dermatitis. Brit J Dermatol. 2000;142:943-946.
35. Devich KB, Lee JC, Epstein WL, Spitler LE, Hopper JJ. Renal lesions accompanying poison oak dermatitis. Clin Nephrol. 1975;3(3):106-113.
36. Fisher AA. Poison ivy/oak dermatitis. Part 1: prevention-soap and water, topical barriers, hyposensitization. Cutis. 1996;57:384-386.
37. Stibich AS, Yagan M, Sharma V, Herndon B, Montgomery C. Cost-effective post-exposure prevention of poison ivy dermatitis. Int J Dermatol. 2000;39:515-518.
38. Armstrong WP, Epstein WL. Poison oak: more than just scratching the surface. Herbalgram. 1995;34:36.
39. Davila A, Lucas J, Laurora M, Jacoby J, Reed J, Heller M. A new topical agent, Zanfel, ameliorates urushiol-induced Toxicodendron allergic contact dermatitis [abstract 364]. Annals Emerg Med. 2003;42(suppl 4):s98.
40. Williford PM, Sherertz EF. Poison ivy dermatitis-nuances in treatment. Arch Fam Med. 1994;3:184-188.
41. Long D, Ballentine NH, Marks JG. Treatment of oison ivy/oak allergic contact dermatitis with an extract of jewel-weed. Am J Contact Dermatitis. 1997;8(3):150-153.
42. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tocrolimus in the treatment of atopic dermatitis: meta-analysis of randomized controlled trials. BMJ. 2005;330:516-525.
43. Amrol D, Keitel D, Hagaman D, Murray J. Topical pimecrolimus in the treatment of human allergic contact dermatitis. Ann Allergy Asthma Immunol. 2003;91(6):563-566.
44. Wooldridge WE. Acute allergic contact dermatitis: how to manage severe cases. Postgrad Med. 1990;87:221-224.
45. Ives TJ. Failure of a tapering dose of oral methylprednisolone to treat reactions to poison ivy. JAMA. 1991;266:1367.
46. Guin JD. Treatment of Toxicodendron dermatitis. Skin Therapy Lett. 2001;6(7):3-5.
47. Marks JG, Trautlein JJ, Epstein WL, Laws DM, Sicard GR. Oral hyposensitization to poison ivy and poison oak. Arch Dermatol. 1987;23(4):476-478.
48. Kawai K, Mikio N, Kyozo K, et al. Hyposensitization to urushiol among Japanese lacquer craftsmen. Contact Dermatol. 1991;25:290-295.
49. McGovern TW. Dermatoses due to plants. In: Bolognia JL, ed. Dermatology. St. Louis, MO: Mosby; 2003:265-283.
50. Oh SH, Haw CR, Lee MH. Clinical and immunologic features of systemic contact dermatitis from ingestion of Rhus (Toxicodendron). Contact Dermatitis. 2003;48:251-254.
51. Grevelink SA. Effectiveness of various barrier preparations in preventing and/or ameliorating experimentally produced Toxicodendron dermatitis. J Am Acad Dermatol. 1992;27:182-188.
52. Marks JG, Fowler JF, Sherertz EF, Rietschel RL. Prevention of poison ivy and poison oak allergic contact dermatitis by quaternium-18 bentonite. J Am Acad Dermatol. 1995;33:212-216.
53. Vidmar DA, Iwane MK. Assessment of the ability of the topical skin protectant (TSP) to protect against contact dermatitis to urushiol antigen. Am J Contact Dermatitis. 1999;10(4):190-197.
54. Baldwin RW, Clegg JA, Curran AC. Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991. Arch Dermatol Res. 1999;291:652-658.